Dear Editor, We read the publication on “Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases” with great interest (1). Lin et al. (1) described “chest computed… Click to show full abstract
Dear Editor, We read the publication on “Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases” with great interest (1). Lin et al. (1) described “chest computed tomography findings of multiple regions of patchy consolidation and ground-glass opacities in both lungs” and mentioned that “these findings were characteristically located along the bronchial bundle or subpleural lungs.” We would like to share ideas and observations from other countries where coronavirus disease 2019 (COVID-19) is also endemic. The computed tomography (CT) findings of COVID-19 are variable. In our setting, some patients have no initial abnormal lung findings and can be misdiagnosed with other common diseases. A recent publication showed that the detection rate of disease is 98% (2). Also, there are different clinical findings in different stages of the disease (3). Use of CT imaging might be useful for assessing the severity of COVID-19, but disease confirmation is still based on molecular diagnosis of the pathogen.
               
Click one of the above tabs to view related content.